Israel Englander’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,398
Closed -$418K 6066
2026
Q1
$418K Buy
+17,398
New +$454K ﹤0.01% 4855
2025
Q4
Sell
-15,498
Closed -$154K 6177
2025
Q3
$154K Sell
15,498
-18,683
-55% -$211K ﹤0.01% 5613
2025
Q2
$310K Buy
+34,181
New +$325K ﹤0.01% 5176
2024
Q4
Sell
-10,638
Closed -$153K 6137
2024
Q3
$153K Buy
+10,638
New +$158K ﹤0.01% 5505
2024
Q2
Sell
-63,811
Closed -$1.27M 6118
2024
Q1
$1.27M Buy
63,811
+52,300
+454% +$645K ﹤0.01% 4097
2023
Q4
$121K Sell
11,511
-7,644
-40% -$76.6K ﹤0.01% 5295
2023
Q3
$169K Sell
19,155
-16,193
-46% -$152K ﹤0.01% 5180
2023
Q2
$341K Sell
35,348
-34,456
-49% -$385K ﹤0.01% 4803
2023
Q1
$963K Buy
69,804
+34,081
+95% +$541K ﹤0.01% 4127
2022
Q4
$543K Sell
35,723
-24,090
-40% -$276K ﹤0.01% 4687
2022
Q3
$544K Sell
59,813
-30,479
-34% -$282K ﹤0.01% 4893
2022
Q2
$765K Buy
+90,292
New +$1.03M ﹤0.01% 4614
2022
Q1
Sell
-30,414
Closed -$740K 7102
2021
Q4
$740K Buy
30,414
+15,316
+101% +$513K ﹤0.01% 4700
2021
Q3
$590K Buy
+15,098
New +$631K ﹤0.01% 5198
2021
Q2
Sell
-19,450
Closed -$663K 6721
2021
Q1
$663K Buy
19,450
+12,238
+170% +$416K ﹤0.01% 4584
2020
Q4
$263K Buy
+7,212
New +$105K ﹤0.01% 4640

Other funds holding GLSI

Israel Englander's GLSI Position: Q2 2026 in Review

Israel Englander sold out of Greenwich LifeSciences (GLSI) in Q2 2026, closing a stake of 17,398 shares — an estimated $418K sold.

Israel Englander first reported a position in GLSI in Q4 2020 and held it in 16 quarters. The position peaked at $1.27M in Q1 2024. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Israel Englander reported no remaining Greenwich LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 17,398 Greenwich LifeSciences shares in Q2 2026, an estimated $418K.
  • Israel Englander first reported a position in Greenwich LifeSciences in Q4 2020 and held it in 16 quarters.
  • Israel Englander's Greenwich LifeSciences position peaked at $1.27M in Q1 2024.
  • 57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.